Table 4a.
Continuous Outcomes | Exposure | ApoE4− (N=1359) | ApoE4+ (N=364) | P-value for Interaction | ||
---|---|---|---|---|---|---|
Beta (SE) | P-value | Beta (SE) | P-value | |||
FAS – No. total responses | Hypertension | 0.10 (0.74) | 0.89 | −3.2 (1.4) | 0.03 | 0.04 |
Animals – No. correct responses | Age | −0.20 (0.01) | <0.0001 | −0.26 (0.03) | <0.0001 | 0.03 |
Hypertension | −0.25 (0.29) | 0.39 | 1.2 (0.58) | 0.04 | 0.03 | |
Trails B-A – Time to completion† | Prevalent CVD | −0.10 (0.03) | 0.003 | 0.07 (0.06) | 0.21 | 0.01 |
Abbreviations: OR = odds ratio; CI=confidence interval; SE=standard error; ApoE4− = apolipoprotein ε4 negative group; ApoE4+ = apolipoprotein ε4 positive group;
All models are adjusted for age, sex, education group (<high school degree, high school degree, college degree, >college degree), and time between risk factor measurement and neuropsychological testing.
Log transformed